FDA Clearance Tracker · K260620
SeptAlign (SPLN001)
Last checked: Nov 19, 2026Latest source record: Jul 30, 2026 (this decision)Source: openFDAMethods & limitations
Decided
Jul 30, 2026
Substantially Equivalent
Time to decision
155 days
Received Feb 25, 2026. Calendar days, including time FDA spent waiting on the applicant.
Pathway
510(k)
Traditional
Device class
Class II
The decision
- FDA number
- K260620
- Device name
- SeptAlign (SPLN001)
- Applicant
- Spirair, Inc.
- Applicant location
- South San Francisco, Ca
- Received
- Feb 25, 2026
- Decided
- Jul 30, 2026
- Decision
- Substantially Equivalent
- Submission type
- Traditional
Device type
- Device class
- Class II
- Regulation
- 21 CFR 874.3620
- Specialty
- Otolaryngology (ENT)
How new is this?
These are facts about FDA's records. They are not a judgment about the device.
- It is not the first decision under product code NHB. The earliest in FDA's data is K012409, decided Oct 18, 2001.
- It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.
Source documents
- FDA database record for K260620
- 510(k) summary (PDF) · FDA posts these some weeks after the decision, so a recent one may not open yet.
The predicate devices this clearance relied on are named in the summary document. We do not extract them yet.
Other decisions for Spirair, Inc.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
- SeptAlign510(k)
K251790 · Decided Jan 16, 2026 · 219 days after receipt
Device type: Polymer, Ear, Nose And Throat, Synthetic, Absorbable (NHB) · Otolaryngology (ENT)
- TurbAlign510(k)
K243655 · Decided Jul 11, 2025 · 227 days after receipt
Device type: Splint, Intranasal Septal (LYA) · Otolaryngology (ENT)
- SeptAlign510(k)
K233569 · Decided Mar 22, 2024 · 137 days after receipt
Device type: Polymer, Ear, Nose And Throat, Synthetic, Absorbable (NHB) · Otolaryngology (ENT)
1 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.